Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-021388

President, R&D sold 10,000 shares at $30.00 ($300,000)

  • President, R&D acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bergstrom Donald A · President, R&D

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-24 Exercise or conversion : show line 1 in the form +10,000 $4.12 $41,200 104,926 D
2022-03-24 Sale : show line 2 in the form −10,000 $30.00 $300,000 94,926 D
Open-market sales · 10,000 sh · avg $30.00 · $300,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-24 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −10,000 217,456 D
Loading xslF345X03/doc4.xml…